DermTopic: Atopic Dermatitis

Filter Your Results

 

News

 

US FDA Grants Dupixent Priority Review for Moderate-to-Sever…

The US Food and Drug Administration (FDA) has granted Priority Review for Dupixent (dupilumab) as a potential treatment …

New AD Estimate: As Many As 16.5 Million Adults Have AD

As many as 16.5 million adults in America have atopic dermatitis (AD). This estimate comes from a new study from the …

EPI Acquires Rights to Cloderm Cream from Promius Pharma

EPI Health has acquired the rights rights to Cloderm® (clocortolone pivalate) Cream, 0.1% and its …

LEO Science and Tech Hub and Epicore Biosystems to Explore W…

LEO Science & Tech Hub has established a new partnership with Epicore Biosystems focused on exploring the …

Almirall and Evotec Form Dermatology Research Collaboration

Alrimal and Evotec aim to discover and develop first-in-class therapeutics through a novel approach to disrupt cell sign…

First-Ever Molecular Study Shows African American Skin React…

African Americans are known to have greater treatment challenges with atopic dermatitis than European Americans and requ…

Inaugural World Eczema Day: GlobalSkin Launches Internationa…

To mark the first-ever Atopic Eczema Day, the International Alliance of Dermatology Patient Organizations (IADPO -- al…

Bee Venom May Help Treat Eczema

Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis, according to a British J…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.